Transgenic

Genome editing in wheat microspores and haploid embryos mediated by delivery of ZFN proteins and cell penetrating peptide complexes

26 days ago   |   By Wiley

Abstract
Recent advances in genome engineering technologies based on designed endonucleases allow specific and predictable alterations in plant genomes to generate value added traits in crops of choice. The EXZACT Precision technology, based on Zinc Finger Nucleases , has been successfully used in the past for introduction of precise mutations and transgenes to generate novel and desired phenotypes in several crop species. Current methods for delivering ZFNs into plant cells are based on traditional genetic transformation methods that result in stable integration of the nuclease in the...
Read more ...

 


Search by Tags

   Transgenic      Protein      Engineering      Plants      Tissue      Genetics      Genomics      Genome  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

How Thermo Fisher Scientific Streamlined Inspection Management With AuditUtopia®

How Thermo Fisher Scientific Streamlined Inspection Management With AuditUtopia®

Case Study Overview In highly regulated industries, you can count on the fact that your company will be inspected a time or two by regulatory agencies and/or your clients. Most... Read more ...

Cover Picture: Biotechnology Journal 12/2019

Cover Picture: Biotechnology Journal 12/2019

Microbial poly‐3‐hydroxybutyrate has been produced via microbial fermentation and safely used as feed additives for sea based large yellow croakers and sensitive land based... Read more ...

A Peek into the Battery Technology Pipeline

A Peek into the Battery Technology Pipeline

Berkeley Lab battery researcher Gerbrand Ceder Lithium ion is probably the most advanced technology available for the packs of rechargeable batteries you'll buy this holiday... Read more ...

Long-Read Sequencing Could Improve the Sensitivity and Precision of 16S...

Long-Read Sequencing Could Improve the Sensitivity and Precision of 16S Sequencing Says Jackson Lab Study

It's time to revisit the way scientists are using 16S rRNA gene sequencing to study microorganisms, according to a team of Jackson Laboratory researchers. Popular targets for... Read more ...

Iterum's Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink

Iterum's Antibiotic for Super Bugs Falls Short in Phase 3, Shares Sink

Iterum Therapeutics' bid to bring patients a new antibiotic that's safer than currently available drugs has fallen short of the main efficacy goal of a late-stage clinical... Read more ...

Flagship's Cellarity Aims to Advance Cell Behavior-Based Therapeutics

Flagship's Cellarity Aims to Advance Cell Behavior-Based Therapeutics

The latest startup to emerge from Flagship Pioneering aims to change drug discovery by starting the process with a clear understanding of cell behavior. Cellarity-like many... Read more ...

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

A KalVista Pharmaceuticals eye drug at the center of a research collaboration with Merck has failed a mid-stage clinical trial. KalVista developed its drug, KVD001, to treat... Read more ...

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Pharmaceuticals is banking on small molecules for cancer-leaving the “cool technologies” aside for a “tried and true” approach, says the CEO, who wants to let the... Read more ...

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other... Read more ...

From Hawaii to PECASE award: tips of success from a female bioinformatician

Read more ...